Diagnostic significance of the novel biomarker combination for early-stage non-small cell lung cancer detection: results of the blind clinical study
The results of the study demonstrated that the TM combination allows increasing the Specificity for patients with indeterminate pulmonary nodules detected by CT scans and improves the accuracy of differential diagnosis.
Authors
- S. A. Tsurkan (ORCID: https://orcid.org/0000-0002-0030-1802)
- Marina Sekacheva (ORCID: https://orcid.org/0000-0003-0015-7094)
- Janneta Tcherkassova (ORCID: https://orcid.org/0000-0002-9074-7233)
- Alexander Boroda (ORCID: https://orcid.org/0000-0002-4196-6042)
- Anna Prostyakova (ORCID: https://orcid.org/0000-0001-5922-6600)
- Yuliya N. Pirogova (ORCID: https://orcid.org/0000-0002-6434-3155)
- Leonid N. Bagmet
- Evgueni Klinski (ORCID: https://orcid.org/0009-0005-5089-8423)
Institutions
- Sechenov University (RU)
- Institute of Bioorganic Chemistry (RU)
- Alpha Cancer Technologies (CA)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-05-19
- DOI
- https://doi.org/10.3389/fonc.2025.1508563
- Citations
- 1
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.52